Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Hepatogastroenterology ; 40(2): 194-5, 1993 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-8509055

RESUMEN

In adults, congenital stricture of the common hepatic duct that does not cause jaundice is very rare. In this report we present a case of a congenital web occluding the common hepatic duct at the level of the bifurcation that was diagnosed by endoscopic retrograde cholangiography.


Asunto(s)
Colestasis Extrahepática/congénito , Conducto Hepático Común , Adulto , Colangiopancreatografia Retrógrada Endoscópica , Colestasis Extrahepática/diagnóstico por imagen , Femenino , Humanos
2.
Acta Gastroenterol Belg ; 68(4): 432-4, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-16432996

RESUMEN

Sarcoidosis is a chronic granulomatous multisystemic disorder of unknown aetiology. Although interferon gamma has been implicated in the pathogenesis of sarcoidosis, only a few cases of sarcoidosis associated with interferon alpha therapy have been reported. We report a case with chronic hepatitis C (CHC) who developed sarcoidosis after the treatment by interferon alpha and ribavirin. The combination therapy of interferon alpha and ribavirin was given to a 50-year-old female with CHC who had not responded to a previous treatment by interferon alpha. She has been admitted with non-productive cough, dyspnoea and fever 11 months after the initiation of combination therapy. Chest x-ray and thorax computed tomography revealed bilateral hilar masses and nodular infiltrations in the lung parenchyma. Pulmonary function test showed a mild restriction. Biopsy of mediastinal lymphadenopathy revealed noncaseating granuloma. She was diagnosed to have pulmonary sarcoidosis at stage II, and the combination treatment was discontinued. Her symptoms regressed after inhaler steroid treatment. Six months after the diagnosis of sarcoidosis, the patient was asymptomatic and a complete sustained response to hepatitis C was achieved. During the three years of follow-up, both pulmonary sarcoidosis and hepatitis C have not recurred. We suggest that sarcoidosis may develop in chronic hepatitis C patients during interferon alpha and/or ribavirin treatment, and diagnostic tests for this adverse effect should be performed during the follow-ups.


Asunto(s)
Hepatitis C Crónica/tratamiento farmacológico , Interferón-alfa/efectos adversos , Ribavirina/efectos adversos , Sarcoidosis Pulmonar/inducido químicamente , Dolor Abdominal/diagnóstico , Dolor Abdominal/etiología , Biopsia con Aguja , Quimioterapia Combinada , Femenino , Estudios de Seguimiento , Hepatitis C Crónica/patología , Humanos , Inmunohistoquímica , Interferón alfa-2 , Interferón-alfa/uso terapéutico , Pruebas de Función Hepática , Persona de Mediana Edad , Proteínas Recombinantes , Ribavirina/uso terapéutico , Medición de Riesgo , Sarcoidosis Pulmonar/patología , Índice de Severidad de la Enfermedad , Tomografía Computarizada por Rayos X
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA